Our study showing ACE2, the entry receptor for SARS-CoV-2, as an interferon-stimulated gene is now out in Cell here. Read about the study in The Boston Globe and MIT News, C&EN, NIH Director’s blog, among others. Datasets analyzed in this study are described here and can be downloaded from our single-cell portal here. We hope these data prove invaluable in the global fight against the COVID-19 pandemic.
Study Describing ACE2 as an Interferon-Stimulated Gene Out in Cell